MediXall (MDXL) Capital Expenditures (2020 - 2021)
MediXall's Capital Expenditures history spans 2 years, with the latest figure at -$12840.0 for Q4 2021.
- For Q4 2021, Capital Expenditures fell 207.54% year-over-year to -$12840.0; the TTM value through Dec 2021 reached $56100.0, down 32.16%, while the annual FY2022 figure was $1379.0, 64.17% up from the prior year.
- Capital Expenditures reached -$12840.0 in Q4 2021 per MDXL's latest filing, down from $840.0 in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $56160.0 in Q3 2020 to a low of -$12840.0 in Q4 2021.